TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32493460

Group type: EXPERIMENTAL
Intervention: CoVideo (E-E video about COVID-19 hygiene)
Number of subjects: 20100

Group type: COMPARATOR
Intervention: APC video (attention placebo control video)
Number of subjects: 20100

Group type: COMPARATOR
Intervention: No video (control group)
Number of subjects: 20100
Study: 36058804

Group type: EXPERIMENTAL
Intervention: Photodynamic Diagnosis-guided Laser Photocoagulation of Bladder Tumor (PC-BT) in outpatient department using a 980 nm diode laser
Number of subjects: 176

Group type: COMPARATOR
Intervention: Transurethral Resection of Bladder Tumor (TUR-BT) in general anesthesia
Number of subjects: 176
Study: 32835826

Group type: EXPERIMENTAL
Intervention: Opioid treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alternative analgesic agents
Number of subjects: 0
Study: 32737760

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous thoracic paravertebral block (TPVB) in group T
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided continuous thoracic paravertebral block (TPVB) in group P
Number of subjects: 150

Group type: COMPARATOR
Intervention: Continuous epidural analgesia in group E
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: All groups (T, P, E)
Number of subjects: 150
Study: 32453396

Group type: EXPERIMENTAL
Intervention: DHA (465 mg) plus vitamin E (600 IU)
Number of subjects: 180

Group type: COMPARATOR
Intervention: DHA (465 mg) plus placebo
Number of subjects: 180

Group type: COMPARATOR
Intervention: 600 IU vitamin E plus placebo
Number of subjects: 180

Group type: COMPARATOR
Intervention: Both placebo capsules
Number of subjects: 180
Study: 33431087

Group type: EXPERIMENTAL
Intervention: Sertraline
Number of subjects: 576

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 576
Study: 34465716

Group type: EXPERIMENTAL
Intervention: Deproteinized bovine bone combined with gelatin sponge (test group, n=28)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Deproteinized bovine bone (control group, n=26)
Number of subjects: 54
Study: 33389719

Group type: EXPERIMENTAL
Intervention: Food Addiction (FA) symptom criteria met
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Food Addiction (FA) symptom criteria not met
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Food Addiction (FA) symptom criteria met but not impairment/distress
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Comparison of age at onset of overweight
Number of subjects: 83
Study: 35603411

Group type: EXPERIMENTAL
Intervention: Beetroot juice (BRJ) 70 mL (400 mg of nitrate)
Number of subjects: 14
Study: 32295483

Group type: EXPERIMENTAL
Intervention: Cognitive training (CT) programme for 12 weeks, 45 min twice a week
Number of subjects: 147

Group type: COMPARATOR
Intervention: Control group (day care as usual)
Number of subjects: 147
Study: 32274500

Group type: EXPERIMENTAL
Intervention: Brief Behavioral Therapy for Cancer‐Related Insomnia (BBT‐CI)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Sleep hygiene pamphlet (control)
Number of subjects: 74
Study: 35152531

Group type: COMPARATOR
Intervention: 5% minoxidil
Number of subjects: 40
Study: 34107473

Group type: EXPERIMENTAL
Intervention: Cholecalciferol 800 IE/day for 12 weeks (healthy individuals)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Cholecalciferol adapted to serum levels for 12 weeks (hemodialysis patients)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo for 12 weeks (healthy individuals)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Placebo for 12 weeks (hemodialysis patients)
Number of subjects: 136
Study: 32621465

Group type: EXPERIMENTAL
Intervention: Navigational dual-target high-frequency rTMS (10 Hz) applied over the primary motor cortex (M1) and left dorsolateral prefrontal cortex (DLPFC) for 20 daily sessions over 3 weeks.
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo rTMS (10 Hz) applied over the same areas for 20 daily sessions over 3 weeks.
Number of subjects: 46
Study: 34633666

Group type: EXPERIMENTAL
Intervention: Fresh RBC transfusions (≤7 days)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Old RBC transfusions (≥21 days)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stored RBC transfusion in mice with immune hemolysis
Number of subjects: 40

Group type: COMPARATOR
Intervention: Stored RBC transfusion in mice with ITP
Number of subjects: 40
Study: 32937023

Group type: EXPERIMENTAL
Intervention: telmisartan/amlodipine 80/5 mg + rosuvastatin 20 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: telmisartan 80 mg + rosuvastatin 20 mg
Number of subjects: 202

Group type: COMPARATOR
Intervention: telmisartan/amlodipine 80/5 mg
Number of subjects: 202
Study: 32370544

Group type: EXPERIMENTAL
Intervention: Combined HI‐AIT & IMT
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 34731917

Group type: EXPERIMENTAL
Intervention: Enoxaparin
Number of subjects: 402

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 402
Study: 32125718

Group type: EXPERIMENTAL
Intervention: Tissue expander
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional vertical GBR
Number of subjects: 46
Study: 35871600

Group type: EXPERIMENTAL
Intervention: CAF + CCM + rhPDGF
Number of subjects: 30

Group type: COMPARATOR
Intervention: CAF + CCM + saline
Number of subjects: 30
Study: 33721444

Group type: EXPERIMENTAL
Intervention: Cetuximab combined with IMRT and concurrent cisplatin‐based chemotherapy
Number of subjects: 126

Group type: COMPARATOR
Intervention: IMRT combined with concurrent cisplatin‐based chemotherapy (Control group)
Number of subjects: 126
Study: 35750460

Group type: EXPERIMENTAL
Intervention: Bearberry (dry extract of Uvae ursi folium)
Number of subjects: 504

Group type: COMPARATOR
Intervention: Fosfomycin (3 g single dose) and two placebo tablets three times a day for 7 days
Number of subjects: 504
Study: 33124762

Group type: EXPERIMENTAL
Intervention: ELLIPTA dry-powder inhaler (DPI)
Number of subjects: 222
Study: 33938936

Group type: EXPERIMENTAL
Intervention: Nivolumab-Ipilimumab combination therapy
Number of subjects: 0
Study: 34817540

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) with intensive lower extremity resistance training (RT) 3 times per week over 12 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard moderate intensity continuous training (MCT) with moderate intensive RT
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: High-intensity interval training with resistance training (HIIT-RT)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Standard CR exercise training
Number of subjects: 56
Study: 32366948

Group type: EXPERIMENTAL
Intervention: Helicobacter pylori (Hp) sero-positivity with periodontal pathogens (e.g., Prevotella intermedia, Campylobacter Rectus, Actinomyces Naeslundii)
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Higher levels of Actinomyces Naeslundii (An)
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Fusobacterim nucleatum (Fn) and Factor 1 (including Fn)
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Probing depth and clinical attachment loss (CAL)
Number of subjects: 1431

Group type: EXPERIMENTAL
Intervention: Selected periodontal pathogen titers, factors, and clusters
Number of subjects: 1431
Study: 33186193

Group type: EXPERIMENTAL
Intervention: Chewing sugar-free gum 3 times a day for 45 minutes after removal of nasogastric tubes until first flatus;
Number of subjects: 34

Group type: COMPARATOR
Intervention: Routine care (Control);
Number of subjects: 34
Study: 35394395

Group type: EXPERIMENTAL
Intervention: IC ECG
Number of subjects: 344

Group type: COMPARATOR
Intervention: Traditional CVAD insertion
Number of subjects: 344
Study: 34610254

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% dosed twice daily
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Latanoprost 0.005% dosed nightly
Number of subjects: 121

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Timolol
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Latanoprost
Number of subjects: 121

Group type: COMPARATOR
Intervention: Comparison of Timolol and Latanoprost
Number of subjects: 121
Study: 32771106

Group type: EXPERIMENTAL
Intervention: Surgery (early surgical fixation)
Number of subjects: 439

Group type: COMPARATOR
Intervention: Cast immobilisation
Number of subjects: 439
Study: 34741280

Group type: EXPERIMENTAL
Intervention: Ceftaroline fosamil (600 mg every 12 hours or 600 mg every 8 hours)
Number of subjects: 1808

Group type: COMPARATOR
Intervention: Vancomycin plus aztreonam (1 g every 12 hours for vancomycin and 1 g every 8 hours for aztreonam)
Number of subjects: 1808
Study: 32285709

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT) for 14 days by enemas from five faecal donors
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Faecal microbiota transplantation (FMT)
Number of subjects: 9
Study: 36173041

Group type: EXPERIMENTAL
Intervention: Gluten-free diet (14 days)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Gluten-containing diet (14 g/day gluten for 14 days)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gluten-free diet
Number of subjects: 20
Study: 33030391

Group type: COMPARATOR
Intervention: Test supplement
Number of subjects: 43

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study: 33150745

Group type: EXPERIMENTAL
Intervention: GnRHAG (gonadotropin‐releasing hormone agonist) for 24 weeks (n = 14)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: GnRHAG + Exercise for 24 weeks (n = 11)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo for 24 weeks (n = 9)
Number of subjects: 34
Study: 33272351

Group type: EXPERIMENTAL
Intervention: Weighted allele score MR (WAS‐MR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Inverse variance weighted MR (IVW‐MR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Weighted median MR (WM‐MR)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MR‐Egger
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Conditional analysis framework utilizing maternal and offspring genotypes
Number of subjects: 0
Study: 33123853

Group type: EXPERIMENTAL
Intervention: Activating spinal orthosis
Number of subjects: 18
Study: 33162369

Group type: EXPERIMENTAL
Intervention: GA-guided multidisciplinary clinic recommendations (decline, defer, proceed)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: AutoHCT recipients
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: GA-identified functional deficits (frail grip strength, poor performance status)
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Patients deferred but ultimately receiving autoHCT
Number of subjects: 91
Study: 32229469

Group type: EXPERIMENTAL
Intervention: Push notifications related to mood
Number of subjects: 1565

Group type: EXPERIMENTAL
Intervention: Push notifications related to activity
Number of subjects: 1565

Group type: EXPERIMENTAL
Intervention: Push notifications related to sleep
Number of subjects: 1565
Study: 35078574

Group type: EXPERIMENTAL
Intervention: Leptin (50, 100, 200, 400 ng/mL)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Leptin (after knockdown of MMP14 and leptin receptor genes)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no leptin treatment)
Number of subjects: 0
Study: 34605920

Group type: COMPARATOR
Intervention: Control
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Process
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Outcomes
Number of subjects: 764

Group type: EXPERIMENTAL
Intervention: Process plus Outcomes
Number of subjects: 764
Study: 34643808

Group type: EXPERIMENTAL
Intervention: SPPF plus EMD
Number of subjects: 13

Group type: COMPARATOR
Intervention: SPPF alone
Number of subjects: 13
Study: 34267461

Group type: EXPERIMENTAL
Intervention: Thromboelastometry-based protocol (ROTEM)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Routine practices including conventional coagulation testing and clinical judgments (Control)
Number of subjects: 80
Study: 34939265

Group type: EXPERIMENTAL
Intervention: Audience Response System (ARS)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Traditional Lecture
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Combination of ARS and Traditional Lecture
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: ARS
Number of subjects: 83
Study: 32144973

Group type: EXPERIMENTAL
Intervention: Neural Mobilization Group (NMG)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Electrotherapy Group (ETG)
Number of subjects: 41
Study: 33123587

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Control group (diet and exercise instruction)
Number of subjects: 1052

Group type: COMPARATOR
Intervention: Control group (oral Chinese and western medicine)
Number of subjects: 1052
Study: 35757326

Group type: EXPERIMENTAL
Intervention: G‐CSF (10 mcg/kg/day subcutaneously)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (1 mL of 0.9% saline subcutaneously)
Number of subjects: 37
Study: 33837422

Group type: EXPERIMENTAL
Intervention: e-cigarettes
Number of subjects: 64
Study: 35954716

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (women)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Multi-strain probiotic (men)
Number of subjects: 0
Study: 33579631

Group type: EXPERIMENTAL
Intervention: Instrument tray optimization using Lean methodology
Number of subjects: 35
Study: 35830173

Group type: EXPERIMENTAL
Intervention: Berdazimer gel, 10.3%
Number of subjects: 891

Group type: COMPARATOR
Intervention: Vehicle gel
Number of subjects: 891
Study: 32046952

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 35486590

Group type: EXPERIMENTAL
Intervention: Comprehensive community facilities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Integrated community facilities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Community facilities
Number of subjects: 0

Group type: COMPARATOR
Intervention: Academic facilities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Community centers post-Z0011 trial
Number of subjects: 0
Study: 34029680

Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg/d
Number of subjects: 4401

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401
Study: 32685547

Group type: EXPERIMENTAL
Intervention: Pittsburgh Sleep Quality Index (PSQI) assessment in caregivers
Number of subjects: 551

Group type: COMPARATOR
Intervention: Sleep duration and habitual sleep efficiency in caregivers
Number of subjects: 551
Study: 32238014

Group type: EXPERIMENTAL
Intervention: Isotretinoin (20 mg/d) plus topical treatments (clobetasol 0.05% and tacrolimus 0.1%)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Monotherapy with topical treatments (clobetasol 0.05% and tacrolimus 0.1%)
Number of subjects: 38
Study: 33635735

Group type: EXPERIMENTAL
Intervention: ART initiation regardless of CD4 count
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Health worker communication
Number of subjects: 134
Study: 32737891

Group type: EXPERIMENTAL
Intervention: Use of preventive dental services
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Being a former smoker
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Self-report of very poor/poor oral health
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Self-report of fair oral health
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Self-reported dental disease
Number of subjects: 638

Group type: EXPERIMENTAL
Intervention: Self-reported gingival disease
Number of subjects: 638
Study: 35747237

Group type: EXPERIMENTAL
Intervention: Allogeneic mesenchymal stem/stromal cells (MSC)
Number of subjects: 14

Group type: COMPARATOR
Intervention: High molecular weight hyaluronic acid (HA)
Number of subjects: 14
Study: 33218556

Group type: EXPERIMENTAL
Intervention: Classical Swedish massage (7 minutes on each posterior thigh for 5 consecutive days)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Superficial stroking (control group)
Number of subjects: 34
Study: 37267172

Group type: EXPERIMENTAL
Intervention: Video directly observed therapy (video DOT) for 12 weeks via a mobile health technology platform
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Video directly observed therapy (video DOT)
Number of subjects: 39
Study: 33107163

Group type: EXPERIMENTAL
Intervention: Sleep
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sleep Deprivation
Number of subjects: 60
Study: 34674397

Group type: EXPERIMENTAL
Intervention: CO2 insufflation
Number of subjects: 76

Group type: COMPARATOR
Intervention: Room air insufflation
Number of subjects: 76
Study: 34108586

Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography screening
Number of subjects: 788897
Study: 33807135

Group type: EXPERIMENTAL
Intervention: High-fat (HF) dairy group incorporating ≥3 servings/day
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Low-fat (LF) dairy group incorporating ≥3 servings/day
Number of subjects: 111

Group type: COMPARATOR
Intervention: Control group maintaining baseline dairy intake
Number of subjects: 111
Study: 35459259

Group type: EXPERIMENTAL
Intervention: PPFP intervention
Number of subjects: 21000

Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 21000
Study: 33515489

Group type: EXPERIMENTAL
Intervention: Ropeginterferon alfa‐2b
Number of subjects: 0

Group type: COMPARATOR
Intervention: Phlebotomy
Number of subjects: 0
Study: 32250672

Group type: EXPERIMENTAL
Intervention: Housing Prescriptions as Health Care (integrating priority placement in affordable housing and provision of services such as case management, financial, and legal services)
Number of subjects: 78

Group type: COMPARATOR
Intervention: Standard of care (providing resource guides and hospital‐based social work or care navigation services)
Number of subjects: 78
Study: 36267872

Group type: EXPERIMENTAL
Intervention: Tropifexor 30 μg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Tropifexor 60 μg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Tropifexor 90 μg
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Tropifexor 150 μg
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Tropifexor (all doses)
Number of subjects: 61
Study: 32665587

Group type: EXPERIMENTAL
Intervention: Mendelian randomization estimates using unrelated individuals
Number of subjects: 283376

Group type: EXPERIMENTAL
Intervention: Within-family Mendelian randomization analyses
Number of subjects: 283376
Study: 35701800

Group type: EXPERIMENTAL
Intervention: Mifepristone
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Ulipristal acetate
Number of subjects: 20
Study: 34153228

Group type: EXPERIMENTAL
Intervention: Lavender aromatherapy inhaler
Number of subjects: 44
Study: 33327697

Group type: EXPERIMENTAL
Intervention: Nasopharyngeal airway
Number of subjects: 148

Group type: COMPARATOR
Intervention: Laryngeal mask airway
Number of subjects: 148
Study: 36271352

Group type: EXPERIMENTAL
Intervention: Subcutaneous ketamine (0.5 mg/kg)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Intravenous ketamine (40-min infusion)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study: 34487870

Group type: EXPERIMENTAL
Intervention: Benralizumab 30 mg every 4 or 8 weeks
Number of subjects: 446

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 446
Study: 33609052

Group type: EXPERIMENTAL
Intervention: Fidaxomicin
Number of subjects: 135

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 135
Study: 34274006

Group type: EXPERIMENTAL
Intervention: Qualitative process evaluations of recruitment strategies in the ACTIVE and PRESTO studies.
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Qualitative semi-structured interviews with patients and health professionals.
Number of subjects: 59
Study: 35798228

Group type: EXPERIMENTAL
Intervention: Method 1 (geometric cloud mapping)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Method 2 (quantitative measurements from Camp et al)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Method 3 (quantitative measurements from Frangiamore et al)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Geometric cloud technique
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Humeral anchor deviations
Number of subjects: 0
Study: 32513905

Group type: EXPERIMENTAL
Intervention: 18F‐FLT PET
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: TACE
Number of subjects: 18
Study: 34676424

Group type: EXPERIMENTAL
Intervention: Insulin glargine
Number of subjects: 7017

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 7017
Study: 34904132

Group type: EXPERIMENTAL
Intervention: Crizanlizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 32662191

Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Sertraline
Number of subjects: 200
Study: 33964910

Group type: EXPERIMENTAL
Intervention: remestemcel‐L
Number of subjects: 29

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 29
Study: 36163942

Group type: EXPERIMENTAL
Intervention: Tamibarotene/Azacitidine
Number of subjects: 190

Group type: COMPARATOR
Intervention: Placebo/Azacitidine
Number of subjects: 190
Study: 33823928

Group type: EXPERIMENTAL
Intervention: AMPS + exercise
Number of subjects: 0

Group type: COMPARATOR
Intervention: exercise
Number of subjects: 0
Study: 32026323

Group type: EXPERIMENTAL
Intervention: Direct texting method
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Nurse screening method
Number of subjects: 103

Group type: COMPARATOR
Intervention: Randomized controlled trial
Number of subjects: 103
Study: 33078338

Group type: EXPERIMENTAL
Intervention: Robotic-assisted revisional bariatric surgery (R-RBS)
Number of subjects: 167
Study: 34031987

Group type: EXPERIMENTAL
Intervention: Web-based training program for social workers
Number of subjects: 1384
Study: 34358673

Group type: EXPERIMENTAL
Intervention: Elastic compression stockings (ECS)
Number of subjects: 232

Group type: COMPARATOR
Intervention: Control group (not wearing ECS)
Number of subjects: 232
Study: 35317213

Group type: EXPERIMENTAL
Intervention: App-based physical exercise program (14 weeks, unsupervised, self-selected frequency and duration)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 110
Study: 32247709

Group type: EXPERIMENTAL
Intervention: Watching comedy videos
Number of subjects: 88

Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 88
Study: 35797863

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 72

Group type: COMPARATOR
Intervention: Sham control
Number of subjects: 72